Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

When It Comes to Money, "Either the Average austrian...

Summary by Die Presse
Research with China is needed for therapies against neurodiseases, says Thomas Streimelweger from the biotech company a:head bio. Patents no longer offer sufficient protection.

1 Articles

Die PresseDie Presse
Lean Right

When It Comes to Money, "Either the Average austrian...

Research with China is needed for therapies against neurodiseases, says Thomas Streimelweger from the biotech company a:head bio. Patents no longer offer sufficient protection.

·Vienna, Austria
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Die Presse broke the news in Vienna, Austria on Sunday, March 22, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Technology icon

Technology

Money icon

Money

Research icon

Research

Germany icon

Germany

Germany Economy icon

Germany Economy

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal